Literature DB >> 8692744

Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.

E Pop1, F Soti, M E Brewster, Y Barenholz, V Korablyov, R Mechoulam, V Nadler, A Biegon.   

Abstract

PURPOSE: Amino acid esters containing tertiary or quaternary nitrogen heterocycles were synthesized for dexanabinol (1) and evaluated as water-soluble prodrugs or congeners.
METHODS: Syntheses were performed by conventional methods; stability studies in water, blood (rat, dog, human) and assay-media were performed by HPLC; NMDA receptor binding was determined by [3H] MK-801 displacement; neuroprotection and neurotoxicity studies were performed in cortical cell cultures.
RESULTS: 7-morpholino and N-methylpiperazino acetates and butyrates and the respective N-methylmorpholinium and piperazinium iodides as well as a 3'-N-methyl morpholino butyrate and the corresponding N-methyl quaternary type derivative were synthesized. All compounds were relatively soluble in water or 10% aqueous ethanol. The examined derivatives were stable in water and generally less stable in blood and assay media. Quaternary derivatives of dexanabinol were found to hydrolyze faster. All examined compounds inhibited NMDA receptor and protected neurons against NMDA induced toxicity. Neuroprotection (with one exception) is however attributed to the parent 1 released by hydrolysis during the assay.
CONCLUSIONS: Some of the examined derivatives could be further evaluated as prodrugs on congeners of 1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692744     DOI: 10.1023/a:1016017331353

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker.

Authors:  J J Feigenbaum; F Bergmann; S A Richmond; R Mechoulam; V Nadler; Y Kloog; M Sokolovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Water-soluble derivatives of 3-oxy-substituted 1,4-benzodiazepines.

Authors:  A Nudelman; R J McCaully; S C Bell
Journal:  J Pharm Sci       Date:  1974-12       Impact factor: 3.534

3.  HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture.

Authors:  N Eshhar; S Striem; A Biegon
Journal:  Neuroreport       Date:  1993-12-13       Impact factor: 1.837

4.  Derivatives of Dexanabinol. I. Water-soluble salts of glycinate esters.

Authors:  E Pop; Z Z Liu; M E Brewster; Y Barenholz; V Korablyov; R Mechoulam; V Nadler; A Biegon
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

5.  Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils.

Authors:  A Bar-Joseph; Y Berkovitch; J Adamchik; A Biegon
Journal:  Mol Chem Neuropathol       Date:  1994 Oct-Dec

6.  Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid.

Authors:  M Vered; A Bar-Joseph; L Belayev; Y Berkovich; A Biegon
Journal:  Acta Neurochir Suppl (Wien)       Date:  1994

7.  A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

Authors:  E Shohami; M Novikov; R Mechoulam
Journal:  J Neurotrauma       Date:  1993       Impact factor: 5.269

8.  Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist.

Authors:  N Eshhar; S Striem; R Kohen; O Tirosh; A Biegon
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.